Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis

Hypersensitivity pneumonitis (HP) is an immunologically mediated form of lung disease resulting from inhalational exposure to any of a large variety of antigens. A subgroup of patients with HP develops pulmonary fibrosis (fibrotic HP; FHP), a significant cause of morbidity and mortality. This study...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ERJ Open Res
Päätekijät: Fernández Pérez, Evans R., Crooks, James L., Swigris, Jeffrey J., Solomon, Joshua J., Mohning, Michael P., Huie, Tristan J., Koslow, Matthew, Lynch, David A., Groshong, Steve D., Fier, Kaitlin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: European Respiratory Society 2021
Aiheet:
Study Protocols
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181708/
https://ncbi.nlm.nih.gov/pubmed/34109243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00054-2021
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia